Sign in
CompletedNo phase

Early Pregnancy Serum Ferritin Levels as a Predictor for Gestational Diabetes Mellitus

Key facts

Who runs it
Zagazig University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
556 people enrolled
Started
5 Dec 2022
Ended
10 Oct 2025
Type of study
Observational, 2 groups
Treatments tested
  • Glycemic Markers
Record updated
25 February 2026

Who can take part

Age
21 years to 40 years
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Confirmed pregnancy at an early gestational age
  • Provision of clinical and family history (e.g., age, BMI, history of GDM)

Who cannot take part

  • Pre-existing Type 1 or Type 2 Diabetes Mellitus
  • Conditions known to significantly alter iron metabolism independent of pregnancy

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This prospective study evaluates a target population of pregnant women at the time of pregnancy diagnosis to investigate the predictive value of serum ferritin (SF) levels for the later development of gestational diabetes mellitus (GDM). The intervention involves measuring early-pregnancy SF, transferrin, and hemoglobin levels, alongside HbA1c, and comparing these biomarkers between women who later develop GDM and those who remain normoglycemic. The primary outcome is to assess the success rate of this diagnostic regimen in identifying high-risk individuals, aiming to establish SF as a valuable early biomarker for GDM to enable timely interventions.

The 2 groups in the trial

  • GDM Group

    Pregnant women who develop gestational diabetes mellitus later in pregnancy.

    Treatment: Glycemic Markers

  • Non GDM Group

    Pregnant women who maintain normal glucose tolerance throughout pregnancy.

    Treatment: Glycemic Markers

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
High Serum Ferritin Early in Pregnancy May Predict the Development of Gestational Diabetes Later.
Record updated
25 February 2026